Investing Ideas
/
South Korean Pharmaceuticals & Biotech Large Cap High Growth Potential

South Korean Pharmaceuticals & Biotech Large Cap High Growth Potential

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.

1 companies

ALTEOGEN

Market Cap: ₩19.7t

A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.

A196170

₩369,000.00

1.2%

11.8%